Status:
UNKNOWN
Prospective, Controlled, Randomized Multicentric Study on the Management of the Vesical Catheter in Colon Surgery.
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Colon Cancer
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
INTRODUCTION: Recommendations for peroperative bladder catheterization remain a controversial issue since it is a procedure that is not without complications. Most of the current suggestions derive fr...
Detailed Description
INTRODUCTION: The usual recommendations for a peroperative bladder catheter vary from surgical reasons to the control of hemodynamics or personal preferences, so since it is not a procedure free of co...
Eligibility Criteria
Inclusion
- Any patient who understands, agrees to participate and signs the informed consent
- older than 18 years-old
- electively operated and programmed laparoscopically of the colon and upper rectum in which peritoneal reflection has not been opened
- duration of the surgical act less than 180 minutes
- Prior anesthetic assessment of ASA I-III
- International prostate symptom score (IPSS) of less than 19 with / without treatment for BPH (alpha-blocker).
Exclusion
- \- Open surgery or conversion to open surgery
- Performing periodic anesthesia or being ASA IV
- Preoperative diagnosis of recurrent urinary tract infections (more than 3 episodes / year documented by urinoculture or two urinary tract infections in the last 6 months);
- Moderate-severe prostate clinic (IPSS\> 19)
- Presence of positive urine culture in men in preoperative tests
- Urinary infection clinic in women with positive urine culture
- Previous history of acute urine retention
- be a permanent bladder catheter or ureteral catheter and perform intermittent autocatheterization.
- men who underwent prostate surgery
- patients with a history of treatment for urological tumor - patients with a history of urethral stricture, enterovesical fistula or previous pelvic surgery.
- urinary incontinence or neurogenic bladder
- chronic renal failure (CRF) with creatinine levels greater than 2 (including terminal CRI stage or dialysis)
- emergency surgery pregnant
- have received pelvic radiotherapy
- Administration of serum during the operative time\> 2,000ml.
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT04070898
Start Date
September 15 2019
End Date
December 31 2022
Last Update
November 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Parc Tauli de Sabadell
Sabadell, Barcelona, Spain, 08208